BS EN ISO 10993-13:2010
Explore BS EN ISO 10993-13:2010 for thorough biocompatibility evaluations of medical device materials, ensuring safety and compliance in healthcare technology.
BS EN ISO 10993-13:2010 is a pivotal standard in the field of healthcare technology, providing essential guidelines for the evaluation of the biocompatibility of medical devices. This document is crucial for manufacturers and stakeholders involved in the production and assessment of medical devices that may interact with biological systems.
Dating from October 31, 2010, the standard is identified as identical to ISO 10993-13:2010, establishing consistent criteria for tests and evaluations on biological materials. The focus of this standard lies on the particular tests necessary for assessing the potential cytotoxic effects of materials used in medical devices, which are fundamental to ensure safety and effectiveness in various healthcare applications.
The BS EN ISO 10993-13:2010 outlines a systematic approach to identifying and mitigating risk factors associated with the toxicity of medical device materials. It provides a framework for conducting in vitro and in vivo trials, helping manufacturers adhere to regulatory requirements while enhancing patient safety. The rigorous methodologies prescribed must be adopted during the design and testing phases, ensuring that any cytotoxic reactions are identified early in the development cycle.
This standard serves not only as a reference for compliance but also as a foundation for improving the quality and performance of healthcare technologies. Adopting its principles can significantly reduce the risk of adverse biological effects, ultimately leading to more effective and safer medical devices for patient care.
With a price point of £220.00, the BS EN ISO 10993-13:2010 is an essential investment for organizations committed to excellence in medical device manufacturing. It not only supports compliance with international standards but also promotes innovation through rigorous testing and validation of materials. By choosing this standard, manufacturers demonstrate their commitment to high-quality outcomes and patient safety, ensuring their products meet the expectations of regulatory bodies and healthcare professionals.
Available in PDF and hardcopy formats, this standard is easily accessible for your organization’s needs. In a landscape where regulatory landscapes are constantly evolving, possessing up-to-date standards like the BS EN ISO 10993-13:2010 is critical for maintaining compliance and ensuring the holistic safety of medical products.
Technical Information
Specification Details
- Biological evaluation of medical devices - Identification and quantification of degradation products from polymeric medical devices